Skip to main content

Critical Appraisal of the Milwaukee Protocol for Rabies: This Failed Approach Should Be Abandoned

  • Frederick A. Zeiler (a1) and Alan C. Jackson (a2) (a3)

The Milwaukee protocol has been attributed to survival in rabies encephalitis despite a lack of scientific evidence supporting its therapeutic measures. We have reviewed the literature with reference to specific treatment recommendations made within the protocol. Current literature fails to support an important role for excitotoxicity and cerebral vasospasm in rabies encephalitis. Therapies suggested in the Milwaukee protocol include therapeutic coma, ketamine infusion, amantadine, and the screening/prophylaxis/management of cerebral vasospasm. None of these therapies can be substantiated in rabies or other forms of acute viral encephalitis. Serious concerns over the current protocol recommendations are warranted. The recommendations made by the Milwaukee protocol warrant serious reconsideration before any future use of this failed protocol.

Évaluation critique du protocole de Milwaukee pour le traitement de la rage: cette approche inefficace devrait être abandonnée. La survie dans l’encéphalite rabique a été attribuée au protocole de Milwaukee malgré l’absence de données scientifiques à l’appui. Nous avons revu la littérature traitant des recommandations spécifiques de traitement faites dans le cadre de ce protocole. Aucune donnée de la littérature actuelle ne supporte que l’excitotoxicité et le vasospasme cérébral jouent un rôle important dans l’encéphalite rabique. Les traitements suggérés dans le protocole de Milwaukee incluent le coma thérapeutique, l’infusion de kétamine, l’amantadine et le dépistage, la prévention et le traitement du vasospasme cérébral. Il n’existe aucune preuve que de ces traitements soient efficaces contre la rage ou toute autre forme d’encéphalite virale aigüe. Il est donc justifié d’entretenir de graves réserves au sujet des recommandations contenues dans le protocole actuel. Les recommandations contenues dans le protocole de Milwaukee méritent d’être reconsidérées dans leur ensemble avant toute utilisation future du protocole actuel qui s’est avéré inefficace.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Critical Appraisal of the Milwaukee Protocol for Rabies: This Failed Approach Should Be Abandoned
      Available formats
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Critical Appraisal of the Milwaukee Protocol for Rabies: This Failed Approach Should Be Abandoned
      Available formats
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Critical Appraisal of the Milwaukee Protocol for Rabies: This Failed Approach Should Be Abandoned
      Available formats
Corresponding author
Correspondence to: Dr. Alan C. Jackson, Health Sciences Centre, GF-543, 820 Sherbrook Street,Winnipeg, MB R3A 1R9 Canada. E-mail:
Hide All
1. Fooks, AR, Banyard, AC, Horton, DL, Johnson, N, McElhinney, L, Jackson, AC. Current status of rabies and prospects for elimination. Lancet. 2014;384:1389-1399.
2. Jackson, AC, Warrell, MJ, Rupprecht, CE, et al. Management of rabies in humans. Clin Infect Dis. 2003;36:60-63.
3. Jackson, AC. Therapy of human rabies. In: Jackson AC, editor. Rabies: scientific basis of the disease and its management, Third Edition. Oxford, UK: Elsevier Academic Press, 2013: p. 573-587.
4. Willoughby, RE Jr., Tieves, KS, Hoffman, GM, et al. Survival after treatment of rabies with induction of coma. N Engl J Med. 2005;352:2508-2514.
5. Hu, WT, Willoughby, RE Jr., Dhonau, H, Mack, KJ. Long-term follow-up after treatment of rabies by induction of coma (Letter). N Engl J Med. 2007;357:945-946.
6. Willoughby, RE Jr. Milwaukee Protocol, version 4.0. 2012. Available from Accessed on August 18, 2015.
7. Maier, T, Schwarting, A, Mauer, D, et al. Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus. Clin Infect Dis. 2010;50:1112-1119.
8. Bagchi, S. Coma therapy. The Telegraph. July 4, 2005. Calcutta.
9. Hemachudha, T, Sunsaneewitayakul, B, Desudchit, T, et al. Failure of therapeutic coma and ketamine for therapy of human rabies. J Neurovirol. 2006;12:407-409.
10. Houston Chronicle Rabies, human - USA (Texas). ProMED-mail.2006;20060513.1360: Available at Accessed August 18, 2015.
11. Christenson, JC, Holm, BM, Lechlitner, S, et al. Human rabies--Indiana and California, 2006. MMWR. 2007;56:361-365.
12. Aramburo, A, Willoughby, RE, Bollen, AW, et al. Failure of the Milwaukee Protocol in a child with rabies. Clin Infect Dis. 2011;53:572-574.
13. McDermid, RC, Saxinger, L, Lee, B, et al. Human rabies encephalitis following bat exposure: failure of therapeutic coma. Can Med Assoc J. 2008;178:557-561.
14. Drosten, C. Rabies - Germany (Hamburg) ex Morocco. ProMED-mail.2007;20070419.1287: April 19, 2007. Available at Accessed August 18, 2015.
15. van Thiel, PP, de Bie, RM, Eftimov, F, et al. Fatal human rabies due to Duvenhage virus from a bat in Kenya: failure of treatment with coma-induction, ketamine, and antiviral drugs. PLoS Neglected Tropical Diseases. 2009;3:e428.
16. Rubin, J, David, D, Willoughby, RE Jr., et al. Applying the Milwaukee Protocol to treat canine rabies in Equatorial Guinea. Scand J Infect Dis. 2009;41:372-375.
17. Pue, HL, Turabelidze, G, Patrick, S, et al. Human rabies - Missouri, 2008. MMWR. 2009;58:1207-1209.
18. Turabelidze, G, Pue, H, Grim, A, Patrick, S. First human rabies case in Missouri in 50 years causes death in outdoorsman. Mo Med. 2009;106:417-419.
19. Caicedo, Y, Paez, A, Kuzmin, I, et al. Virology, immunology and pathology of human rabies during treatment. Pediatr Infect Dis J. 2015;34:520-528.
20. Jackson, AC, Garland, A. Fatal rabies case did not die “accidentally” and should not be considered a rabies survivor (Letter). Pediatr Infect Dis J. 2015;34:677-678.
21. Badillo, R, Mantilla, JC, Pradilla, G. Human rabies encephalitis by a vampire bat bite in an urban area of Colombia (Spanish). Biomédica. 2009;29:191-203.
22. Hunter, M, Johnson, N, Hedderwick, S, et al. Immunovirological correlates in human rabies treated with therapeutic coma. J Med Virol. 2010;82:1255-1265.
23. Blanton, JD, Palmer, D, Rupprecht, CE. Rabies surveillance in the United States during 2009. J Am Vet Med Assoc. 2010;237:646-657.
24. Luminos, M, Barboi, G, Draganescu, A, et al. Human rabies in a Romanian boy - an ante mortem case study. Rabies Bull Europe. 2011;35:5-10.
25. Santos, A, Cale, E, Dacheux, L, Bourhy, H, Gouveia, J, Vasconcelos, P. Fatal case of imported human rabies in Amadora, Portugal, August 2011. Eurosurveillance. 2012;17:20130.
26. Javaid, W, Amzuta, IG, Nat, A, et al. Imported human rabies in a U.S. Army soldier - New York, 2011. MMWR Morb Mortal Wkly Rep. 2012;61:302-305.
27. Nat, A, Nat, A, Sharma, A, Pothineni, A, AmzutaI, I. Looking beyond the Milwaukee Protocol (Abstract). Chest. 2014;145:117A.
28. Greer, DM, Robbins, GK, Lijewski, V, Gonzalez, RG, McGuone, D. Case records of the Massachusetts General Hospital: Case 1-2013: a 63-year-old man with paresthesias and difficulty swallowing. N Engl J Med. 2013;368:172-180.
29. NE 10 Rabies, human - Brazil (03): (Ceara). ProMED-mail..2012;20120314.1070531: March 14, 2012. Available at Accessed August 18, 2015.
30. Branswell, H. Testing suggests Toronto rabies case infected in Dominican Republic. The Globe and Mail. April 19, 2012. Toronto.
31. Times Live Rabies - South Africa (02): (Kwazulu-Natal), human ex Mozambique. ProMED-mail.2012;20120528.1147931: May 28, 2012. Available at Accessed August 18, 2015.
32. Rabies - South Africa (03): (Kwazulu-Natal), human ex Mozambique. ProMED-mail.2012;20120608.1160328: June 8, 2012. Available at Accessed August 18, 2015.
33. Pathak, S, Horton, DL, Lucas, S, et al. Diagnosis, management and post-mortem findings of a human case of rabies imported into the United Kingdom from India: a case report. Virol J. 2014;11:63.
34. Wallace, RM, Bhavnani, D, Russell, J, et al. Rabies death attributed to exposure in Central America with symptom onset in a U.S. detention facility - Texas, 2013. MMWR Morb Mortal Wkly Rep. 2014;63:446-449.
35. Chen, YG, Kan, LP, Lee, CH, et al. Symptomatic hypercalcemia in a rabies survivor underwent hemodialysis. Hemodial Int. 2015;19:347-351.
36. Ramya, M. Madras Christian College student, a dog lover, dies of rabies. The Times of India. February 22, 2014. Chennai.
37. Elsiesy, H, Hussain, I, Abaalkhail, FA, et al. Rabies outbreak involving four transplant recipients in Kuwait and Saudi Arabia. Presentation at the XXVIth International Meeting on Research Advances and Rabies Control in the Americas in Fort Collins, Colorado, USA on October 5, 2015.
38. Al Mousawi, MSA. Transmission of rabies virus from a deceased organ donor to six recipients in Kuwait and Saudi Arabia. Presented at the 2015 Organ Donation Congress in Seoul, South Korea on October 18, 2015.
39. Wiedeman, J, Plant, J, Glaser, C, et al. Recovery of a patient from clinical rabies - California, 2011. MMWR. 2012;61:61-65.
40. Ministerio da Saude in Brazil Rabies, human survival, bat - Brazil: (Pernambuco). ProMED-mail.2008;20081114.3599: Available at Accessed August 18, 2015.
41. Holzmann-Pazgal, G, Wanger, A, Degaffe, G, et al. Presumptive abortive human rabies - Texas, 2009. MMWR. 2010;59:185-190.
42. Palmer, A, McVey, E, McNeill, KM, et al. Human rabies--Mississippi, 2005. MMWR. 2006;55:207-208.
43. Blanton, JD, Hanlon, CA, Rupprecht, CE. Rabies surveillance in the United States during 2006. J Am Vet Med Assoc. 2007;231:540-556.
44. Yee, AH, Merrell, RT, Zubkov, AY, et al. Human rabies--Minnesota, 2007. MMWR Morb Mortal Wkly Rep. 2008;57:460-462.
45. Fukagawa, C, Alvarez, F, Messenger, S, et al. Imported human rabies--California, 2008. MMWR Morb Mortal Wkly Rep. 2009;58:713-716.
46. House, J, Poe, J, Humbaugh, K, et al. Human rabies - Kentucky/Indiana, 2009. MMWR Morb Mortal Wkly Rep. 2010;59:393-396.
47. Signs, K, Stobierski, MG, Rupprecht, CE, Robertson, K. Human rabies --- Michigan, 2009. MMWR Morb Mortal Wkly Rep. 2011;60:437-440.
48. Troell, P, Miller-Zuber, B, Ondrush, J, et al. Human rabies --- Virginia, 2009. MMWR. 2010;59:1236-1238.
49. Balsamo, G, Ratard, RC, Thoppil, DR, et al. Human rabies from exposure to a vampire bat in Mexico --- Louisiana, 2010. MMWR Morb Mortal Wkly Rep. 2011;60:1050-1052.
50. Kazmierczak, JJ, Davis, JP, Brauer, E, Recuenco, S, Rupprecht, CE, Bartholomew, M. Human rabies --- Wisconsin, 2010. MMWR Morb Mortal Wkly Rep. 2011;60:1164-1166.
51. Prasek, D, Mamon, R, Stepanyuk, O, et al. Imported human rabies - New Jersey, 2011. MMWR Morb Mortal Wkly Rep. 2012;60:1734-1736.
52. Vora, NM, Basavaraju, SV, Feldman, KA, et al. Raccoon rabies virus variant transmission through solid organ transplantation. JAMA. 2013;310:398-407.
53. Blanton, JD, Dyer, J, McBrayer, J, Rupprecht, CE. Rabies surveillance in the United States during 2011. J Am Vet Med Assoc. 2012;241:712-722.
54. Rupprecht, CE, Brenner, E, Cox, S, et al. Human rabies - South Carolina, 2011. MMWR Morb Mortal Wkly Rep. 2013;62:642-644.
55. Farley, S, Zarate, S, Jenssen, E, et al. U.S-acquired human rabies with symptom onset and diagnosis abroad, 2012. MMWR Morb Mortal Wkly Rep. 2012;61:777-781.
56. Reinke, SN, Resch, L, Maingut, F, et al. Metagenomic and metabolomic characterization of rabies encephalitis: new insights into the treatment of an ancient disease. J Inf Dis. 2013;207:1451-1456.
57. Solomon, T, Marston, D, Mallewa, M, et al. Paralytic rabies after a two week holiday in India. BMJ. 2005;331:501-503.
58. Johnson, N, Brookes, SM, Fooks, AR, Ross, RS. Review of human rabies cases in the UK and in Germany. Vet Rec. 2005;157:715.
59. Lau, A, Tymianski, M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch. 2010;460:525-542.
60. Di, X, Bullock, R, Watson, J, et al. Effect of CP101,606, a novel NR2B subunit antagonist of the N-methyl-D-aspartate receptor, on the volume of ischemic brain damage off cytotoxic brain edema after middle cerebral artery occlusion in the feline brain. Stroke. 1997;28:2244-2251.
61. Morris, GF, Bullock, R, Marshall, SB, Marmarou, A, Maas, A, Marshall, LF. Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two phase III clinical trials. The Selfotel Investigators. J Neurosurg. 1999;91:737-743.
62. Hoyte, L, Barber, PA, Buchan, AM, Hill, MD. The rise and fall of NMDA antagonists for ischemic stroke. Curr Mol Med. 2004;4:131-136.
63. Giacino, JT, Whyte, J, Bagiella, E, et al. Placebo-controlled trial of amantadine for severe traumatic brain injury. N Engl J Med. 2012;366:819-826.
64. Nargi-Aizenman, JL, Havert, MB, Zhang, M, Irani, DN, Rothstein, JD, Griffin, DE. Glutamate receptor antagonists protect from virus-induced neural degeneration. Ann Neurol. 2004;55:541-549.
65. Mori, I, Liu, B, Hossain, MJ, et al. Successful protection by amantadine hydrochloride against lethal encephalitis caused by a highly neurovirulent recombinant influenza A virus in mice. Virology. 2002;303:287-296.
66. Robertson, WC Jr., Clark, DB, Markesbery, WR. Review of 38 cases of subacute sclerosing panencephalitis: effect of amantadine on the natural course of the disease. Ann Neurol. 1980;8:422-425.
67. Darman, J, Backovic, S, Dike, S, et al. Viral-induced spinal motor neuron death is non-cell-autonomous and involves glutamate excitotoxicity. J Neurosci. 2004;24:7566-7575.
68. Nargi-Aizenman, JL, Griffin, DE. Sindbis virus-induced neuronal death is both necrotic and apoptotic and is ameliorated by N-methyl-D-aspartate receptor antagonists. J Virol. 2001;75:7114-7121.
69. Kaul, M, Lipton, SA. Neuroinflammation and excitotoxicity in neurobiology of HIV-1 infection and AIDS: targets for neuroprotection. In: Malva JO, Rego AC, Cunha RA, Oliveira CR, editors. Interaction between neurons and glia in aging and disease. New York: Springer Science, 2007: p. 281-308.
70. Weli, SC, Scott, CA, Ward, CA, Jackson, AC. Rabies virus infection of primary neuronal cultures and adult mice: failure to demonstrate evidence of excitotoxicity. J Virol. 2006;80:10270-10273.
71. Glezer, I, Zekki, H, Scavone, C, Rivest, S. Modulation of the innate immune response by NMDA receptors has neuropathological consequences. J Neurosci. 2003;23:11094-11103.
72. Appolinario, CM, Jackson, AC. Antiviral therapy for human rabies. Antivir Ther. 2015;22:1-10.
73. Lockhart, BP, Tordo, N, Tsiang, H. Inhibition of rabies virus transcription in rat cortical neurons with the dissociative anesthetic ketamine. Antimicrob Agents Chemother. 1992;36:1750-1755.
74. Schifilliti, D, Grasso, G, Conti, A, Fodale, V. Anaesthetic-related neuroprotection: intravenous or inhalational agents? Cns Drugs. 2010;24:893-907.
75. Roberts, I, Sydenham, E. Barbiturates for acute traumatic brain injury. Cochrane Database Syst Rev. 2012;12:CD000033.
76. Kramer, AH. Viral encephalitis in the ICU. Crit Care Clin. 2013;29:621-649.
77. Shehabi, Y, Chan, L, Kadiman, S, et al. Sedation depth and long-term mortality in mechanically ventilated critically ill adults: a prospective longitudinal multicentre cohort study. Intensive Care Med. 2013;39:910-918.
78. Wieske, L, Chan Pin Yin, DR, Verhamme, C, Schultz, MJ, van Schaik, IN, Horn, J. Autonomic dysfunction in ICU-acquired weakness: a prospective observational pilot study. Intensive Care Med. 2013;39:1610-1617.
79. Schmidt, H, Hoyer, D, Wilhelm, J, et al. The alteration of autonomic function in multiple organ dysfunction syndrome. Crit Care Clin. 2008;24:149-163; ix.
80. Willoughby, RE, Roy-Burman, A, Martin, KW, et al. Generalised cranial artery spasm in human rabies. In: Dodet B, Fooks AR, Müller T, Tordo N, editors. Towards the elimination of rabies in Eurasia. Basel: Kager, 2008: p. 367-375.
81. Sing, TM, Soo, MY. Imaging findings in rabies. Australas Radiol. 1996;40:338-341.
82. Budohoski, KP, Guilfoyle, M, Helmy, A, et al. The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2014;85:1343-1353.
83. Willoughby, RE, Opladen, T, Maier, T, et al. Tetrahydrobiopterin deficiency in human rabies. J Inherit Metab Dis. 2009;32:65-72.
84. Marshall, SA, Nyquist, P, Ziai, WC. The role of transcranial Doppler ultrasonography in the diagnosis and management of vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurg Clin N Am. 2010;21:291-303.
85. Rigamonti, A, Ackery, A, Baker, AJ. Transcranial Doppler monitoring in subarachnoid hemorrhage: a critical tool in critical care. Can J Anaesth. 2008;55:112-123.
86. Hanggi, D. Monitoring and detection of vasospasm II: EEG and invasive monitoring. Neurocrit Care. 2011;15:318-323.
87. Dorhout Mees, SM, Rinkel, GJ, Feigin, VL, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007:CD000277.
88. Langham, J, Goldfrad, C, Teasdale, G, Shaw, D, Rowan, K. Calcium channel blockers for acute traumatic brain injury. Cochrane Database Syst Rev. 2003:CD000565.
89. Kawakami, M, Kodama, N, Toda, N. Suppression of the cerebral vasospastic actions of oxyhemoglobin by ascorbic acid. Neurosurgery. 1991;28:33-39.
90. Banic, S. Prevention of rabies by vitamin c. Nature. 1975;258:153-154.
91. Perko, D, Pretnar-Oblak, J, Sabovic, M, Zvan, B, Zaletel, M. Differences between cerebrovascular reactivity to L-arginine in the anterior and posterior cerebral circulation. Cerebrovasc Dis. 2011;31:358-364.
92. Diringer, MN, Bleck, TP, Claude, HJ III, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15:211-240.
93. Velat, GJ, Kimball, MM, Mocco, JD, Hoh, BL. Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature. World Neurosurg. 2011;76:446-454.
94. Jackson, AC. Current and future approaches to the therapy of human rabies. Antiviral Res. 2013;99:61-67.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Canadian Journal of Neurological Sciences
  • ISSN: 0317-1671
  • EISSN: 2057-0155
  • URL: /core/journals/canadian-journal-of-neurological-sciences
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed